Department of Thyroid Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
J Clin Endocrinol Metab. 2020 Jul 1;105(7). doi: 10.1210/clinem/dgaa182.
Lysine-specific demethylase 1 (LSD1) stabilizes hypoxia-inducible factor 1α (HIF1α) to advance tumor progression, while HIF1α functions as a transcription factor to increase the expression of microRNA-146a (miR-146a).
We aim to investigate whether LSD1 affects the development of papillary thyroid carcinoma (PTC) via HIF1α and miR-146a.
In vitro assays were performed with Nthy-ori 3-1, BHP5-16, BCPAP, K1, and BHP2-7 cell lines. In vivo assays were conducted with established xenograft tumors in nude mice.
This study was conducted at our lab.
PTC tissues and corresponding adjacent normal tissues were obtained from 45 patients hospitalized in Sun Yat-Sen Memorial Hospital. Assays were conducted using Nthy-ori 3-1, BHP5-16, BCPAP, K1, and BHP2-7 cell lines, as well as 50 male BALB/c nude mice.
Cells were transfected with sh-LSD1, sh-GABPA, oe-LSD1, oe-HIF1α, miR-146a mimic, and miR-146a inhibitor. In addition, K1 cells expressing lv-oe-LSD1, lv-miR-146a inhibitor, lv-oe-LSD1 or miR-146a inhibitor were injected into the right side of the mice. LSD1 gene and protein expression patterns were analyzed in 45 clinical PTC tissue samples.
Expression of LSD1, HIF1α, miR-146a, and GA-binding protein transcription factor alpha (GABPA), as well as their effects on PTC.
LSD1 was highly expressed in clinical PTC tissues. LSD1 stabilized HIF1α and inhibited the degradation of its ubiquitin proteasome. HIF1α was enriched in the promoter region of miR-146a, an upregulated miRNA in PTC. HIF1α increased miR-146a expression to promote PTC progression in vitro, which was achieved by inhibiting GABPA, a target gene of miR-146a. LSD1 upregulated miR-146a to enhance the development and metastasis of PTC in nude mice.
Our results show that LSD1 functions as an oncogene in PTC by upregulating HIF1α and miR-146a, elucidating an understanding of undefined mechanisms associated with tumor progression in PTC.
赖氨酸特异性脱甲基酶 1(LSD1)稳定缺氧诱导因子 1α(HIF1α)以促进肿瘤进展,而 HIF1α 作为转录因子增加 microRNA-146a(miR-146a)的表达。
我们旨在研究 LSD1 是否通过 HIF1α 和 miR-146a 影响甲状腺乳头状癌(PTC)的发生。
在 Nthy-ori 3-1、BHP5-16、BCPAP、K1 和 BHP2-7 细胞系中进行体外实验。在裸鼠建立的移植瘤中进行体内实验。
本研究在我们的实验室进行。
从中山大学孙逸仙纪念医院住院的 45 例患者中获得 PTC 组织和相应的癌旁正常组织。使用 Nthy-ori 3-1、BHP5-16、BCPAP、K1 和 BHP2-7 细胞系以及 50 只雄性 BALB/c 裸鼠进行了检测。
用 sh-LSD1、sh-GABPA、oe-LSD1、oe-HIF1α、miR-146a 模拟物和 miR-146a 抑制剂转染细胞。此外,将表达 lv-oe-LSD1、lv-miR-146a 抑制剂、lv-oe-LSD1 或 miR-146a 抑制剂的 K1 细胞注入小鼠右侧。分析了 45 例临床 PTC 组织标本中 LSD1 基因和蛋白的表达模式。
LSD1、HIF1α、miR-146a 和 GA 结合蛋白转录因子α(GABPA)的表达及其对 PTC 的影响。
LSD1 在临床 PTC 组织中高表达。LSD1 稳定了 HIF1α 并抑制了其泛素蛋白酶体的降解。HIF1α 富集在 PTC 中上调的 miRNA miR-146a 的启动子区域。HIF1α 在体外通过抑制 miR-146a 的靶基因 GABPA 促进 PTC 进展。LSD1 通过上调 miR-146a 增强裸鼠 PTC 的发展和转移。
我们的结果表明,LSD1 通过上调 HIF1α 和 miR-146a 在 PTC 中发挥癌基因作用,阐明了 PTC 中肿瘤进展相关的未定义机制。